(Q36675881)

15 August 2017

1 reference

title

Treatment of diabetic polyneuropathy: Update 2006. (English)

1 reference

15 August 2017

main subject

diabetic polyneuropathy

1 reference

Dan Ziegler

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Annals of the New York Academy of Sciences

15 August 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 August 2017

volume

1084

1 reference

15 August 2017

page(s)

250-266

1 reference

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Consensus and contention in the treatment of chronic nerve-damage pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

Reversal of diabetic peripheral neuropathy with phototherapy (MIRE) decreases falls and the fear of falling and improves activities of daily living in seniors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1372.008

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1372.008

1 reference

15 August 2017

1 reference